Founded
31 Dec 2010
Address
GeneWeave Biosciences Inc
5941 Optical Court
San Jose, CA 95138
United States
GeneWeave Biosciences Inc
983 University Avenue
Building B
Los Gatos, CA 95032
United States
GeneWeave Biosciences Inc
c/o Claremont Creek Ventures LP
3000 Frank H Ogawa Plaza, Suite 350
Oakland, CA 94614
United States
Geneweave Biosciences Inc
C/o Claremont Creek Ventures Lp
3000 Frank H. Ogawa Plaza, Suite 350
Oakland, CA 94614
United States
Geneweave Biosciences Inc
5941 Optical Court
San Jose, CA 95138
United States
Website
Tags
VCID: 483670
Profile
Corporate information
Official name
GeneWeave Biosciences Inc
Registration country
Official name
GeneWeave Biosciences Inc
Registration country
Investment activity status
Active investor
Company type
Developer of a platform for the rapid detection of infectious disease.Funding
Funding rounds
Series B USD 12,000,000
USD 12,000,000 (11 Jun 2014)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Decheng Capital | Follow-on investment. Led the round. | |||
Claremont Creek Ventures | Venture capital firm investing in early stage information technology companies. | United States | Follow-on investment. Round participant. | |
X/Seed Capital | Seed stage venture capital firm. | United States | Follow-on investment. Round participant. |
Series A USD 12,000,000
USD 12,000,000 (28 Feb 2012)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Decheng Capital | Led the round. | |||
Claremont Creek Ventures | Venture capital firm investing in early stage information technology companies. | United States | Follow-on investment. Round participant. | |
X/Seed Capital | Seed stage venture capital firm. | United States | Follow-on investment. Round participant. |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Claremont Creek Ventures Venture capital firm investing in early stage information technology companies. |
+1 (510) 740-5001 |
Series A Series B |
|
Decheng Capital |
Series A Series B |
||
X/Seed Capital Seed stage venture capital firm. |
Series A Series B |